Immediate Impact
54 standout
Citing Papers
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
2024 Standout
Works of Markus Vosseler being referenced
Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Markus Vosseler | 114 | 78 | 127 | 24 | 328 | |
| T Utsunomiya | 72 | 99 | 79 | 30 | 334 | |
| Braghadheeswar Thyagarajan | 86 | 97 | 138 | 24 | 344 | |
| Sümeyye Güllülü | 130 | 66 | 48 | 41 | 316 | |
| Michal Pořízka | 99 | 108 | 66 | 28 | 257 | |
| Francesca Ziviello | 130 | 54 | 91 | 24 | 259 | |
| Hongsheng Ren | 65 | 60 | 84 | 27 | 305 | |
| Yasuhisa Wakabayashi | 85 | 109 | 59 | 23 | 337 | |
| Mücahid Yılmaz | 90 | 63 | 54 | 27 | 280 | |
| Claire K. Mulvey | 62 | 64 | 122 | 24 | 343 | |
| Dilek Erer | 97 | 115 | 91 | 38 | 319 |
All Works
Loading papers...